Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2018, Article ID 8765285, 3 pages
https://doi.org/10.1155/2018/8765285
Case Report

Prolonged Survival of Acute Lymphoblastic Leukemia with Intrathecal Treatments for Isolated Central Nervous System Relapse

1Rutgers Robert Wood Johnson Medical School, 3rd Floor, New Brunswick, NJ, USA
2Hackensack Meridian Health Jersey Shore University, 1945 Route 33, Ackerman Building, 3rd Floor, Neptune, NJ 07753, USA
3Bayer U.S. LLC, 100 Bayer Boulevard, Whippany, NJ 07891-0915, USA

Correspondence should be addressed to Elan Gorshein; moc.liamg@niehsrog.nale

Received 12 December 2017; Revised 29 December 2017; Accepted 3 January 2018; Published 31 January 2018

Academic Editor: Massimo Gentile

Copyright © 2018 Elan Gorshein et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2017,” A Cancer Journal for Clinicians, vol. 67, no. 1, pp. 7–30, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Kansagra, S. Dahiya, and M. Litzow, “Continuing challenges and current issues in acute lymphoblastic leukemia,” Leukemia & Lymphoma, pp. 1–16, 2017. View at Publisher · View at Google Scholar
  3. C. H. Pui and W. E. Evans, “Treatment of acute lymphoblastic leukemia,” New England Journal of Medicine, vol. 354, no. 2, pp. 166–178, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Bassan and D. Hoelzer, “Modern therapy of acute lymphoblastic leukemia,” Journal of Clinical Oncology, vol. 29, no. 5, pp. 532–543, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Faderl, S. O’Brien, C. H. Pui et al., “Adult acute lymphoblastic leukemia: concepts and strategies,” Cancer, vol. 116, no. 5, pp. 1165–1176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Gökbuget, M. Kneba, T. Raff et al., “Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies,” Blood, vol. 120, no. 9, pp. 1868–1876, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Gokbuget, J. Beck, and M. Bruggemann, “Moderate intensive chemotherapy including CNS prophylaxis with liposomal cytarabine is feasible and effective in older patients with Ph− negative acute lymphoblastic leukemia (ALL): results of a prospective trial from the German Multicenter Study Group for Adult ALL (GMALL),” Blood, vol. 120, p. 1493, 2012. View at Google Scholar
  8. N. Gökbuget, “How I treat older patients with ALL,” Blood, vol. 122, no. 8, pp. 1366–1375, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Delannoy, B. Cazin, X. Thomas et al., “Treatment of acute lymphoblastic leukemia in the elderly: an evaluation of interferon alpha given as a single agent after complete remission,” Leukemia & Lymphoma, vol. 43, no. 1, pp. 75–81, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Dass, A. Dayama, P. C. Mishra et al., “Higher rate of central nervous system involvement by flow cytometry than morphology in acute lymphoblastic leukemia,” International Journal of Laboratory Hematology, vol. 39, no. 5, pp. 546–551, 2017. View at Publisher · View at Google Scholar
  11. H. M. Lazarus, S. M. Richards, R. Chopra et al., “Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL-XII/ECOG E2993,” Blood, vol. 108, no. 2, pp. 465–472, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. E. Bromberg, D. A. Breems, J. Kraan et al., “CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies,” Neurology, vol. 68, no. 20, pp. 1674–1679, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. U. R. Surapaneni, J. E. Cortes, D. Thomas et al., “Central nervous system relapse in adults with acute lymphoblastic leukemia,” Cancer, vol. 94, no. 3, pp. 773–779, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. C. H. Pui, “Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment,” Hematology, vol. 2006, no. 1, pp. 142–146, 2006. View at Publisher · View at Google Scholar
  15. J. M. Sancho, J. M. Ribera, A. Oriol et al., “Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis,” Cancer, vol. 106, no. 12, pp. 2540–2548, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. J. Perissinotti and D. J. Reeves, “Role of intrathecal rituximab and trastuzumab in the management of leptomeningeal carcinomatosis,” Annals of Pharmacotherapy, vol. 44, no. 10, pp. 1633–1640, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. C. Jaime-Pérez, L. N. Rodríguez-Romo, O. González-Llano, A. Chapa-Rodríguez, and D. Gómez-Almaguer, “Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy,” British Journal of Haematology, vol. 144, no. 5, pp. 794-795, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Ceppi, S. Weitzman, W. Woessmann et al., “Safety and efficacy of intrathecal rituximab in children with B cell lymphoid CD20+ malignancies: An international retrospective study,” American Journal of Hematology, vol. 91, no. 5, pp. 486–491, 2016. View at Publisher · View at Google Scholar · View at Scopus